Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/1/2020
SIETES contiene 92881 citas

 
 
 1 a 8 de 8 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Roth C, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, Zhang W. Folic acid supplements in pregnancy and severe language delay in children. JAMA 2011;306:1566-73. [Ref.ID 91544]
2. Cita con resumen
Khan S, Justice E, Jobanputra P. Adverse reactions and safety of newer disease-modifying antirheumatic drugs (DRMARDs) for thematoid arthritis. Adv Drug React Bull 2007;242:927-30. [Ref.ID 80952]
3.
Khan S, Sharrack B, Swell WAC. Metronidazole-induced aseptic meningitis during Helicobacter pylori eradication therapy. Ann Intern Med 2007;146:395-6. [Ref.ID 79542]
4.Tiene citas relacionadas Cita con resumen
Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby L K, Waters D, Vittinghoff E, Wenger N, for the HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 2002;288:49-57. [Ref.ID 62687]
5.
O'Rourke F, Steinberg R, Ghosh P, Khan S. Withdrawal of baclofen may cause acute confusion in elderly patients. BMJ 2001;323:870. [Ref.ID 59199]
6. Cita con resumen
Sica DA, Liao W-C, Gehr TWB, Khan S, Jemal M, Delaney CL, Ferreira IM, Malhotra DK. Disposition and safety of omapatrilat in subjects with renal impairment. Clin Pharmacol Ther 2000;68:261-9. [Ref.ID 52602]
7. Cita con resumen
Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Huunighake D, Vittinghoff E, Hulley S, for the Heart and Estrogen/progestin Replacement Study Research Group. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-96. [Ref.ID 50718]
8.Tiene citas relacionadas Cita con resumen
Khan S, Williamson P, Sutton R. Meta-analyses and large randomized, controlled trials. N Engl J Med 1998;338:60. [Ref.ID 36230]
Seleccionar todas
 
 1 a 8 de 8